Richard J. Medalie, brought suit under the Medicare Secondary Payer statute (the “MSP”) against the drug companies that developed, manufactured, and marketed the drug Baycol. Following its decision in Stalley v. Catholic Health Initiatives, Nos. 06-3884, 06-4121, 2007 U.S. App. LEXIS 27331, 2007 WL 4165751 (8th Cir. Nov. 27, 2007), the Court held that an MSP action is not a qui tam action. A plaintiff who lacks any injury in fact does not have standing to pursue an MSP action.
The federal Medicaid statute authorizes the use of individual self-settled special needs trusts for individuals…
If someone is receiving Medicaid and was injured through the negligence of others, Medicaid asserts…
On April 22, 2024, the Centers for Medicare and Medicaid Services announced a new final…
In Creamer v. Manley, decided March 14, 2024, the Court of Appeals affirmed summary judgment…
On February 21, 2024, the Georgia Court of Appeals decided the case of In Re…
The Georgia Court of Appeals decided the case of In re Bessie Mae Blake on…